Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Patients requiring home parenteral nutrition (PN) may develop metabolic bone disease, the etiology of which can be multifactorial. We report a case of significantly low bone mass in a postmenopausal woman with history of short bowel syndrome, renal impairment, and previous radiation exposure who responded to intermittent subcutaneous administration of parathyroid hormone. Her bone mineral density normalized after she completed a course of 18 months of treatment, and a bone isotope scan was negative for skeletal malignancy.

Original publication

DOI

10.1177/0115426506021006605

Type

Journal article

Journal

Nutr clin pract

Publication Date

12/2006

Volume

21

Pages

605 - 609

Keywords

Aged, Bone Density Conservation Agents, Bone Diseases, Metabolic, Female, Gastrointestinal Diseases, Humans, Parenteral Nutrition, Home, Teriparatide